← Back
Data updated: Mar 10, 2026
RECORDATI RARE
Pharmaceuticals
RECORDATI RARE is a major pharmaceutical company with 12 FDA-approved products.
1949
Since
12
Drugs
-
Trials
9
Approved (2yr)
Key Drugs
Recent Activity
ISTURISA 2025-11-04
Manufacturing (CMC)
ISTURISA 2025-07-03
Efficacy
ISTURISA 2025-04-15
Efficacy
INDOCIN 2024-11-21
Labeling
INDOCIN 2024-11-21
Labeling
INDOCIN 2024-11-21
Labeling
CHEMET 2024-09-16
Labeling
SIGNIFOR 2024-07-11
Labeling
SIGNIFOR LAR KIT 2024-07-11
Labeling
SEC Filings
Pro
Loading...
Therapeutic Focus
Score weights: Approved drugs ×3, Phase 3 ×2, Phase 2 ×1, Phase 1 ×0.5
No indication data
Pipeline Strength Pro
Loading...